US Stock MarketDetailed Quotes

ADMA ADMA Biologics

Watchlist
  • 15.960
  • +3.770+30.93%
Close Aug 9 16:00 ET
  • 15.950
  • -0.010-0.06%
Post 20:01 ET
3.72BMarket Cap114.00P/E (TTM)

ADMA Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
853.36%45.65M
84.94%-2.22M
114.79%8.8M
338.46%17.6M
190.22%11.99M
52.78%-6.06M
43.40%-14.72M
47.04%-59.51M
77.95%-7.38M
0.95%-13.28M
Net income from continuing operations
603.25%32.06M
362.28%17.81M
57.15%-28.24M
-44.25%-17.64M
117.22%2.57M
53.72%-6.37M
72.85%-6.79M
8.02%-65.9M
26.54%-12.23M
15.88%-14.9M
Operating gains losses
--1K
27.78%23K
271.37%26.36M
6,168.96%26.25M
1,510.87%92.95K
--0
-99.73%18K
3,111.31%7.1M
197.93%418.65K
146.16%5.77K
Depreciation and amortization
-2.43%2.05M
3.98%2.11M
17.14%8.33M
8.90%2.11M
12.36%2.09M
21.67%2.1M
27.84%2.03M
29.42%7.11M
27.55%1.94M
30.93%1.86M
Other non cash items
-88.28%192K
-84.85%217K
19.59%6.29M
7.52%1.54M
-12.81%1.68M
21.14%1.64M
160.77%1.43M
199.71%5.26M
206.66%1.43M
327.20%1.92M
Change In working capital
267.58%8.48M
-95.73%-24.52M
44.64%-10.12M
99,563.79%3.6M
210.70%3.86M
-51.80%-5.06M
-9.33%-12.53M
64.62%-18.29M
99.98%-3.62K
-300.87%-3.49M
-Change in receivables
290.99%19.51M
-101.58%-22.2M
-191.16%-11.92M
-27.79%3.9M
368.18%5.41M
-251.41%-10.21M
-473.67%-11.01M
185.22%13.07M
165.95%5.4M
-164.04%-2.02M
-Change in inventory
-194.24%-2.08M
-584.54%-4.83M
75.03%-9.63M
-2,571.51%-9.79M
92.07%-1.34M
131.82%2.21M
95.11%-705K
10.73%-38.56M
96.54%-366.46K
-16.74%-16.84M
-Change in prepaid assets
59.88%-869K
-39.20%611K
232.65%841K
919.33%2.07M
84.37%-72.16K
-264.94%-2.17M
361.82%1.01M
79.34%-634K
-63.53%203.48K
44.12%-461.58K
-Change in payables and accrued expense
-249.88%-7.82M
174.92%1.22M
36.42%11.37M
249.94%7.65M
-99.20%127.61K
316.27%5.22M
-1,711.76%-1.63M
-14.06%8.33M
-150.28%-5.1M
16.67%15.94M
-Change in other current liabilities
-145.71%-258K
462.03%677K
-57.57%-791K
-68.14%-229.66K
-143.92%-269.35K
27.05%-105K
-68.37%-187K
-329.22%-502K
-222.55%-136.59K
-163.63%-110.42K
Cash from discontinued investing activities
Operating cash flow
853.36%45.65M
84.94%-2.22M
114.79%8.8M
338.46%17.6M
190.22%11.99M
52.78%-6.06M
43.40%-14.72M
47.04%-59.51M
77.95%-7.38M
0.95%-13.28M
Investing cash flow
Cash flow from continuing investing activities
-171.22%-2.37M
-21.44%-2.36M
64.19%-4.98M
62.46%-1.41M
77.61%-756.79K
77.87%-872K
31.56%-1.95M
-2.96%-13.91M
-1.98%-3.75M
-21.22%-3.38M
Net PPE purchase and sale
-136.93%-2.07M
-20.67%-2.35M
65.70%-4.77M
68.06%-1.2M
77.61%-756.79K
77.87%-872K
31.56%-1.95M
-2.96%-13.91M
-1.98%-3.75M
-21.22%-3.38M
Net intangibles purchase and sale
---299K
---15K
---210K
----
----
--0
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
-171.22%-2.37M
-21.44%-2.36M
64.19%-4.98M
62.46%-1.41M
77.61%-756.79K
77.87%-872K
31.56%-1.95M
-2.96%-13.91M
-1.98%-3.75M
-21.22%-3.38M
Financing cash flow
Cash flow from continuing financing activities
-250.83%-362K
-122.62%-1.45M
-135.82%-38.99M
-162.15%-38.99M
149.18%414.96K
175.23%240K
-101.38%-650K
-10.08%108.85M
16.58%62.74M
-110.29%-843.79K
Net issuance payments of debt
--0
--0
-145.64%-23.6M
-270,400.88%-23.58M
99.70%-28
34.02%-6K
-100.02%-10K
152,200.00%51.71M
-2.66%-8.72K
-6.94%-9.25K
Net common stock issuance
----
----
--0
----
----
----
----
-46.64%64.65M
----
----
Proceeds from stock option exercised by employees
-29.87%331K
--1.03M
530.86%1.1M
-95.17%8.46K
--623.54K
--472K
--0
--175K
--175K
--0
Net other financing activities
-206.64%-693K
-286.88%-2.48M
-114.68%-16.49M
-645.61%-15.42M
75.01%-208.55K
27.08%-226K
85.68%-640K
-12,290.32%-7.68M
-514,271.89%-2.07M
-36,390.77%-834.54K
Cash from discontinued financing activities
Financing cash flow
-250.83%-362K
-122.62%-1.45M
-135.82%-38.99M
-162.15%-38.99M
149.18%414.96K
175.23%240K
-101.38%-650K
-10.08%108.85M
16.58%62.74M
-110.29%-843.79K
Net cash flow
Beginning cash position
-34.51%45.33M
-40.65%51.35M
69.36%86.52M
112.45%74.16M
19.27%62.51M
-0.43%69.2M
69.36%86.52M
-8.64%51.09M
1.44%34.91M
23.59%52.42M
Current changes in cash
741.44%42.92M
65.20%-6.03M
-199.26%-35.17M
-144.18%-22.81M
166.50%11.64M
60.85%-6.69M
-194.04%-17.32M
833.30%35.43M
209.48%51.62M
-118.91%-17.51M
End cash Position
41.16%88.24M
-34.51%45.33M
-40.65%51.35M
-40.65%51.35M
112.45%74.16M
19.27%62.51M
-0.43%69.2M
69.36%86.52M
69.36%86.52M
1.44%34.91M
Free cash flow
724.46%43.28M
72.52%-4.58M
105.20%3.82M
245.49%16.19M
167.38%11.23M
58.67%-6.93M
42.24%-16.67M
41.68%-73.42M
70.04%-11.13M
-2.87%-16.67M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 853.36%45.65M84.94%-2.22M114.79%8.8M338.46%17.6M190.22%11.99M52.78%-6.06M43.40%-14.72M47.04%-59.51M77.95%-7.38M0.95%-13.28M
Net income from continuing operations 603.25%32.06M362.28%17.81M57.15%-28.24M-44.25%-17.64M117.22%2.57M53.72%-6.37M72.85%-6.79M8.02%-65.9M26.54%-12.23M15.88%-14.9M
Operating gains losses --1K27.78%23K271.37%26.36M6,168.96%26.25M1,510.87%92.95K--0-99.73%18K3,111.31%7.1M197.93%418.65K146.16%5.77K
Depreciation and amortization -2.43%2.05M3.98%2.11M17.14%8.33M8.90%2.11M12.36%2.09M21.67%2.1M27.84%2.03M29.42%7.11M27.55%1.94M30.93%1.86M
Other non cash items -88.28%192K-84.85%217K19.59%6.29M7.52%1.54M-12.81%1.68M21.14%1.64M160.77%1.43M199.71%5.26M206.66%1.43M327.20%1.92M
Change In working capital 267.58%8.48M-95.73%-24.52M44.64%-10.12M99,563.79%3.6M210.70%3.86M-51.80%-5.06M-9.33%-12.53M64.62%-18.29M99.98%-3.62K-300.87%-3.49M
-Change in receivables 290.99%19.51M-101.58%-22.2M-191.16%-11.92M-27.79%3.9M368.18%5.41M-251.41%-10.21M-473.67%-11.01M185.22%13.07M165.95%5.4M-164.04%-2.02M
-Change in inventory -194.24%-2.08M-584.54%-4.83M75.03%-9.63M-2,571.51%-9.79M92.07%-1.34M131.82%2.21M95.11%-705K10.73%-38.56M96.54%-366.46K-16.74%-16.84M
-Change in prepaid assets 59.88%-869K-39.20%611K232.65%841K919.33%2.07M84.37%-72.16K-264.94%-2.17M361.82%1.01M79.34%-634K-63.53%203.48K44.12%-461.58K
-Change in payables and accrued expense -249.88%-7.82M174.92%1.22M36.42%11.37M249.94%7.65M-99.20%127.61K316.27%5.22M-1,711.76%-1.63M-14.06%8.33M-150.28%-5.1M16.67%15.94M
-Change in other current liabilities -145.71%-258K462.03%677K-57.57%-791K-68.14%-229.66K-143.92%-269.35K27.05%-105K-68.37%-187K-329.22%-502K-222.55%-136.59K-163.63%-110.42K
Cash from discontinued investing activities
Operating cash flow 853.36%45.65M84.94%-2.22M114.79%8.8M338.46%17.6M190.22%11.99M52.78%-6.06M43.40%-14.72M47.04%-59.51M77.95%-7.38M0.95%-13.28M
Investing cash flow
Cash flow from continuing investing activities -171.22%-2.37M-21.44%-2.36M64.19%-4.98M62.46%-1.41M77.61%-756.79K77.87%-872K31.56%-1.95M-2.96%-13.91M-1.98%-3.75M-21.22%-3.38M
Net PPE purchase and sale -136.93%-2.07M-20.67%-2.35M65.70%-4.77M68.06%-1.2M77.61%-756.79K77.87%-872K31.56%-1.95M-2.96%-13.91M-1.98%-3.75M-21.22%-3.38M
Net intangibles purchase and sale ---299K---15K---210K----------0--0--0--------
Cash from discontinued investing activities
Investing cash flow -171.22%-2.37M-21.44%-2.36M64.19%-4.98M62.46%-1.41M77.61%-756.79K77.87%-872K31.56%-1.95M-2.96%-13.91M-1.98%-3.75M-21.22%-3.38M
Financing cash flow
Cash flow from continuing financing activities -250.83%-362K-122.62%-1.45M-135.82%-38.99M-162.15%-38.99M149.18%414.96K175.23%240K-101.38%-650K-10.08%108.85M16.58%62.74M-110.29%-843.79K
Net issuance payments of debt --0--0-145.64%-23.6M-270,400.88%-23.58M99.70%-2834.02%-6K-100.02%-10K152,200.00%51.71M-2.66%-8.72K-6.94%-9.25K
Net common stock issuance ----------0-----------------46.64%64.65M--------
Proceeds from stock option exercised by employees -29.87%331K--1.03M530.86%1.1M-95.17%8.46K--623.54K--472K--0--175K--175K--0
Net other financing activities -206.64%-693K-286.88%-2.48M-114.68%-16.49M-645.61%-15.42M75.01%-208.55K27.08%-226K85.68%-640K-12,290.32%-7.68M-514,271.89%-2.07M-36,390.77%-834.54K
Cash from discontinued financing activities
Financing cash flow -250.83%-362K-122.62%-1.45M-135.82%-38.99M-162.15%-38.99M149.18%414.96K175.23%240K-101.38%-650K-10.08%108.85M16.58%62.74M-110.29%-843.79K
Net cash flow
Beginning cash position -34.51%45.33M-40.65%51.35M69.36%86.52M112.45%74.16M19.27%62.51M-0.43%69.2M69.36%86.52M-8.64%51.09M1.44%34.91M23.59%52.42M
Current changes in cash 741.44%42.92M65.20%-6.03M-199.26%-35.17M-144.18%-22.81M166.50%11.64M60.85%-6.69M-194.04%-17.32M833.30%35.43M209.48%51.62M-118.91%-17.51M
End cash Position 41.16%88.24M-34.51%45.33M-40.65%51.35M-40.65%51.35M112.45%74.16M19.27%62.51M-0.43%69.2M69.36%86.52M69.36%86.52M1.44%34.91M
Free cash flow 724.46%43.28M72.52%-4.58M105.20%3.82M245.49%16.19M167.38%11.23M58.67%-6.93M42.24%-16.67M41.68%-73.42M70.04%-11.13M-2.87%-16.67M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-4.29%